Buy these two for their government contracts

Article Excerpt

Both Calian and Extendicare have a major plus on their side during this time of COVID-19 uncertainty. Specifically, the two get most of their revenue from governments. For Calian, revenue generated from departments and agencies of the Canadian government currently represents about 69% of the total. And with more than 90% of its business now government funded, Extendicare and its investors are also well positioned to continue to weather the pandemic. CALIAN GROUP $64.00 is a buy. The Ottawa-based company (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (www.calian.com; Shares outstanding: 11.3 million; Market cap: $719.4 million; Dividend yield: 1.8%) lets investors benefit from four main operating segments: Advanced Technologies offers products and engineering services for the space, communications, nuclear, agriculture, defence and government sectors. The Health unit manages a network of more than 1,800 healthcare professionals delivering primary care and occupational health services to public- and private-sector clients across Canada. The Learning division provides specialized training services and solutions for the Canadian…